Fig. 1From: Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trialsCumulative probability plots showing individual patient changes from baseline in mTSS at month 6. BID twice daily, mTSS van der Heijde modified total Sharp score, MTX methotrexate, PBO placeboBack to article page